THOUGHT LEADERSHIP

Clinical research is the indispensable method for determining the safety and efficacy of new treatments for human diseases and conditions. As crucial as dedicated biologists and chemists, medical professionals, clinical operations experts, data managers, and biostatisticians are to successful research, realization would be impossible without the participation of patients and their caregivers. Yet many potential participants, despite their willingness to engage in research, have faced some inhibiting barriers. For many years now, the industry has made progress in easing patient and caregiver burden through ever-advancing technologies. The advent of practical artificial intelligence (AI) tools is another step forward in making clinical research comfortable and attractive to patients.

Drug development and clinical research methods evolve continuously through establishment of new regulations and through adaptations to changes in treatment accessibility, technology, evolving knowledge in biology, and appearance of new diseases. 

Patient-centric trials, in which the perspective of the patient is considered in study design and performance, is one such new approach in clinical research that primarily focuses on reducing patient burden.